Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A0A3S7X993
PDB structure(s): 7ane_ao
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 140 | 144 | PF00656 | 0.354 |
CLV_C14_Caspase3-7 | 262 | 266 | PF00656 | 0.519 |
CLV_NRD_NRD_1 | 259 | 261 | PF00675 | 0.376 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.382 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 259 | 261 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.365 |
CLV_PCSK_PC1ET2_1 | 191 | 193 | PF00082 | 0.405 |
CLV_PCSK_PC7_1 | 255 | 261 | PF00082 | 0.359 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.521 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.521 |
DOC_CYCLIN_yCln2_LP_2 | 38 | 44 | PF00134 | 0.456 |
DOC_MAPK_gen_1 | 11 | 19 | PF00069 | 0.423 |
DOC_MAPK_gen_1 | 26 | 34 | PF00069 | 0.384 |
DOC_MAPK_MEF2A_6 | 110 | 118 | PF00069 | 0.434 |
DOC_PP4_FxxP_1 | 131 | 134 | PF00568 | 0.317 |
DOC_PP4_FxxP_1 | 286 | 289 | PF00568 | 0.384 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.558 |
DOC_USP7_MATH_1 | 269 | 273 | PF00917 | 0.415 |
DOC_WW_Pin1_4 | 199 | 204 | PF00397 | 0.351 |
DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.374 |
DOC_WW_Pin1_4 | 83 | 88 | PF00397 | 0.640 |
LIG_14-3-3_CanoR_1 | 241 | 249 | PF00244 | 0.333 |
LIG_BRCT_BRCA1_1 | 4 | 8 | PF00533 | 0.504 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.446 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.357 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.347 |
LIG_FHA_1 | 59 | 65 | PF00498 | 0.360 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.726 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.449 |
LIG_LIR_Apic_2 | 283 | 289 | PF02991 | 0.403 |
LIG_LIR_Apic_2 | 71 | 77 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 159 | 169 | PF02991 | 0.355 |
LIG_LIR_Nem_3 | 159 | 164 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 16 | 21 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.510 |
LIG_LRP6_Inhibitor_1 | 104 | 110 | PF00058 | 0.401 |
LIG_PTB_Apo_2 | 125 | 132 | PF02174 | 0.301 |
LIG_SH2_CRK | 171 | 175 | PF00017 | 0.377 |
LIG_SH2_CRK | 74 | 78 | PF00017 | 0.450 |
LIG_SH2_NCK_1 | 74 | 78 | PF00017 | 0.459 |
LIG_SH2_STAP1 | 79 | 83 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.346 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.314 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.348 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.512 |
LIG_TYR_ITIM | 169 | 174 | PF00017 | 0.358 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.362 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.491 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.466 |
MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.368 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.360 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.432 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.589 |
MOD_N-GLC_1 | 77 | 82 | PF02516 | 0.402 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.508 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.320 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.417 |
MOD_NEK2_2 | 254 | 259 | PF00069 | 0.350 |
MOD_PIKK_1 | 137 | 143 | PF00454 | 0.514 |
MOD_PIKK_1 | 235 | 241 | PF00454 | 0.362 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.427 |
MOD_PKA_2 | 240 | 246 | PF00069 | 0.337 |
MOD_PKA_2 | 254 | 260 | PF00069 | 0.353 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.372 |
MOD_PKA_2 | 81 | 87 | PF00069 | 0.610 |
MOD_Plk_1 | 282 | 288 | PF00069 | 0.486 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.492 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.354 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.347 |
MOD_ProDKin_1 | 199 | 205 | PF00069 | 0.349 |
MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.370 |
MOD_ProDKin_1 | 83 | 89 | PF00069 | 0.642 |
MOD_SUMO_rev_2 | 16 | 24 | PF00179 | 0.323 |
TRG_DiLeu_BaLyEn_6 | 38 | 43 | PF01217 | 0.494 |
TRG_DiLeu_BaLyEn_6 | 59 | 64 | PF01217 | 0.509 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.324 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.370 |
TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.374 |
TRG_ER_diArg_1 | 258 | 260 | PF00400 | 0.364 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P378 | Leptomonas seymouri | 81% | 100% |
A0A0S4JD50 | Bodo saltans | 57% | 100% |
A0A1X0P6P5 | Trypanosomatidae | 71% | 100% |
A0A422MYC0 | Trypanosoma rangeli | 67% | 100% |
A4HMP6 | Leishmania braziliensis | 92% | 100% |
A4IBB5 | Leishmania infantum | 99% | 100% |
C9ZZD8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 99% |
E9AF47 | Leishmania major | 96% | 100% |
E9B6A3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5BTH8 | Trypanosoma cruzi | 69% | 100% |